Antibodies against HDL components improve the diagnostic accuracy between ischemic stroke or coronary artery disease and healthy controls when added to traditional cardiovascular risk factors. (August 2018) - Batuca, J.; Amaral, M.; Favas, C.; Justino, G.; Papoila, A.; Ames, P.; Delgado Alves, J.